MINNEAPOLIS (July 31, 2020) – Padilla was recognized with the Best in Healthcare Award for its work on The 16 Vaccine educational initiative, during the PRWeek Awards virtual ceremony held July 30, 2020.
Launched in 2018 with the National Meningitis Association (MNA) – one of the nation’s leading drivers of meningitis education – The 16 Vaccine initiative aims to educate parents, particularly mothers, about the importance of the Centers for Disease Control and Prevention (CDC)-recommended second dose of the MenACWY vaccine for their sons or daughters at the age of 16 to protect against meningococcal meningitis.
Now celebrating its 21st year, the PRWeek Awards is one of the communications industry’s highest accolades. It celebrates the best of the best corporate, agency, nonprofit, and education teams, and the work they produce.
Meningococcal meningitis is a rare, but potentially deadly disease that can spread from one teen to the next. Most adolescents get vaccinated against this disease at age 11 or 12. But as of 2019, only half of U.S. teens have received the CDC-recommended second dose of the MenACWY vaccine at age 16, leaving many teens unprotected when they are at increased risk.
Padilla and MNA set out to urge parents to speak with their teen’s healthcare provider about vaccination — with the ultimate aim of increasing MenACWY second dose rates.
A complete list of winners is available on the PRWeek website.
Media contact: Jeff.Wilson@PadillaCo.com